MIDU:ARCA-Direxion Mid Cap Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 54.78

Change

+0.50 (+0.92)%

Market Cap

USD 0.05B

Volume

0.13M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P MidCap? 400 Index. The fund, under normal circumstances, creates long positions by investing at least 80% of its assets in the securities that comprise the S&P MidCap? 400 Index ("index") and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index measures the performance of the mid-cap segment of the U.S. equity universe. The index is a capitalization-weighted index composed of 400 domestic common stocks. The fund is non-diversified.

Inception Date: 08/01/2009

Primary Benchmark: S&P MidCap 400 TR

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.99%

Management Expense Ratio: 1.10 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TARS Tarsus Pharmaceuticals Inc 0.35 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-30 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 12.12B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 6.36B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 5.09B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 4.11B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 3.82B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 3.21B
USD ProShares Ultra Semiconductors 0.95 %

N/A

USD 1.14B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 1.01B
DPST Direxion Daily Regional Banks .. 1.02 %

N/A

USD 0.87B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 0.81B

ETFs Containing MIDU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.46% 70% C- 89% A-
Dividend Return 0.67% 49% F 17% F
Total Return 24.13% 68% D+ 89% A-
Trailing 12 Months  
Capital Gain 22.28% 59% D- 84% B
Dividend Return 1.37% 51% F 20% F
Total Return 23.64% 62% D 82% B
Trailing 5 Years  
Capital Gain 30.65% 58% F 63% D
Dividend Return 2.76% 44% F 8% B-
Total Return 33.41% 58% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 33.40% 69% C- 91% A-
Dividend Return 33.85% 69% C- 90% A-
Total Return 0.45% 37% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 103.55% 34% F 7% C-
Risk Adjusted Return 32.69% 58% F 53% F
Market Capitalization 0.05B 51% F 28% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.